Trial no.:
|
PACTR202008463834676 |
Date of Approval:
|
20/08/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
ClustEr randomisEd Trial of sterile glove And instrument change at the time of wound closure to reduce surgical site infection in Low and Middle Income Countries (LMICs)
|
Official scientific title |
ClustEr randomisEd Trial of sterile glove And instrument change at the time of wound closure to reduce surgical site infection in Low and Middle Income Countries (LMICs) |
Brief summary describing the background
and objectives of the trial
|
Aim: To assess whether the practice of using separate sterile gloves and instruments to close wounds at the end of surgery compared to current routine hospital practice can reduce surgical site infection at 30-days post-surgery for patients undergoing clean-contaminated, contaminated or dirty abdominal surgery.
Design: International, multicentre, 2-arm, cluster randomised controlled trial, with an internal pilot. Clusters are defined as hospitals.
Eligibility:
Countries: LMICs defined by the Development Assistance Committee (DAC) Official Development Assistance (ODA) list where there are at least 4 eligible hospitals per country.
Hospitals (clusters): in LMICs where glove and instrument change is not currently routine hospital practice.
Participants: Patients (adults and children) undergoing emergency or elective abdominal surgery for a clean-contaminated, contaminated, or dirty operation.
Interventions: Before closing the abdominal wall, surgeons and the scrub nurse will change gloves and use separate, sterile instruments, versus current routine hospital practice (of not changing gloves or using separate, sterile instruments).
Outcomes: The primary outcome is SSI 30 days post-surgery, using the Centre for Disease Control (CDC) criteria. Secondary outcomes are SSI before point of hospital discharge, readmission (within 30-days post-surgery), reoperation (within 30-days post-surgery), length of hospital stay, return to normal activities and death (within 30 days of surgery).
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
CHEETAH |
Disease(s) or condition(s) being studied |
Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Change of sterile gloves and sterile set of instruments for abdominal wound closure |
Anticipated trial start date |
01/01/2020 |
Actual trial start date |
03/02/2020 |
Anticipated date of last follow up |
04/01/2021 |
Actual Last follow-up date |
23/06/2022 |
Anticipated target sample size (number of participants) |
12800 |
Actual target sample size (number of participants) |
12800 |
Recruitment status |
Completed |
Publication URL |
https://www.thelancet.com/article/S0140-6736(22)01884-0/fulltext |
|